A Phase 2, Randomized, Double Blind, Parallel Design Study Comparing the Efficacy and Safety of VI-0521 to Placebo in the Glycemic Management of Obese Diabetic Adults
Phase of Trial: Phase II
Latest Information Update: 24 Feb 2015
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors VIVUS
- 24 Feb 2015 Results were presented as per Vivus Inc. media release.
- 01 Jul 2010 Results of this study were presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 07 Oct 2008 Results presented at the Obesity Society Annual Scientific Meeting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History